Theravance Biopharma, Inc. (TBPH)
After hours:
| Previous close | 8.34 |
| Open | 8.40 |
| Bid | 8.39 x 100 |
| Ask | 8.45 x 100 |
| Day's range | 8.15 - 8.43 |
| 52-week range | 8.15 - 11.71 |
| Volume | |
| Avg. volume | 399,967 |
| Market cap | 409.005M |
| Beta (5Y monthly) | 0.36 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced financial and operational results for the first quarter of 2024.
- PR Newswire
Theravance Biopharma to Participate in an Upcoming Investor Conference
Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ Monday, May 20 at 11:30 AM EDT (8:30 AM PDT / 4:30 PM IST) and will be hosting in-person meetings with the investment community at the conference.
- PR Newswire
Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024
Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its first quarter 2024 financial results and provide a business update after market close on Monday, May 13, 2024. An accompanying conference call and simultaneous webcast will be hosted at 5:00 pm ET (2:00 pm PT/10:00 pm IST) that day.
